Nisa Investment Advisors LLC Sells 5,030 Shares of Global Medical REIT Inc. (NYSE:GMRE)

Nisa Investment Advisors LLC lowered its position in Global Medical REIT Inc. (NYSE:GMREFree Report) by 15.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,362 shares of the company’s stock after selling 5,030 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Global Medical REIT were worth $217,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Gordian Capital Singapore Pte Ltd purchased a new stake in Global Medical REIT in the 2nd quarter worth about $100,000. Quantinno Capital Management LP bought a new position in shares of Global Medical REIT during the third quarter valued at approximately $138,000. Zacks Investment Management raised its holdings in shares of Global Medical REIT by 12.9% in the third quarter. Zacks Investment Management now owns 14,803 shares of the company’s stock worth $147,000 after buying an additional 1,696 shares during the period. Intech Investment Management LLC bought a new stake in shares of Global Medical REIT during the 3rd quarter worth approximately $150,000. Finally, Versor Investments LP bought a new stake in shares of Global Medical REIT during the 3rd quarter worth approximately $189,000. Institutional investors own 57.52% of the company’s stock.

Global Medical REIT Price Performance

Global Medical REIT stock opened at $7.85 on Thursday. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28. The stock has a market cap of $524.07 million, a price-to-earnings ratio of -392.05, a price-to-earnings-growth ratio of 1.34 and a beta of 1.23. The firm has a 50-day moving average of $8.16 and a two-hundred day moving average of $8.95. Global Medical REIT Inc. has a 1 year low of $7.33 and a 1 year high of $10.46.

Global Medical REIT (NYSE:GMREGet Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.18). The firm had revenue of $34.26 million during the quarter, compared to analysts’ expectations of $34.88 million. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. During the same quarter in the previous year, the firm posted $0.23 EPS. On average, research analysts forecast that Global Medical REIT Inc. will post 0.81 earnings per share for the current year.

Global Medical REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 8th. Stockholders of record on Friday, December 20th were paid a dividend of $0.21 per share. The ex-dividend date was Friday, December 20th. This represents a $0.84 annualized dividend and a dividend yield of 10.71%. Global Medical REIT’s dividend payout ratio is currently -4,200.00%.

Analyst Ratings Changes

Separately, Berenberg Bank began coverage on Global Medical REIT in a research report on Friday, October 18th. They issued a “buy” rating and a $11.75 price objective on the stock.

View Our Latest Analysis on Global Medical REIT

Global Medical REIT Profile

(Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Further Reading

Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMREFree Report).

Institutional Ownership by Quarter for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.